Abstract
A growing number of clinical trials are evaluating the effects of stem cell therapy in patients with chronic ischemic heart dysfunction. As most of the clinical trials included a limited and different number of patients, various stem cell sources and several delivery approaches, results vary substantially between these studies. We analyse whether the assessment of myocardial viability may be important when evaluating effects of stem cell transplantation on parameters of left ventricular remodeling. Viability assessment could help to find the best type of stem cell and the best method of cell delivery to be used in chronic ischemic heart dysfunction.
Keywords: Stem cell, ischemic heart disease, viability, left ventricular function.
Cardiovascular & Hematological Disorders-Drug Targets
Title: Stem Cell Therapy in Chronic Ischemic Heart Dysfunction with and Without Viability
Volume: 10 Issue: 3
Author(s): Pedro L. Sanchez, Ricardo Sanz-Ruiz, M. Eugenia Fernandez-Santos, Adolfo Villa, Enrique Gutierrez, Lucia Fernandez, Sandra Vazquez, M. Jose Lorenzo and Francisco Fernandez-Aviles
Affiliation:
Keywords: Stem cell, ischemic heart disease, viability, left ventricular function.
Abstract: A growing number of clinical trials are evaluating the effects of stem cell therapy in patients with chronic ischemic heart dysfunction. As most of the clinical trials included a limited and different number of patients, various stem cell sources and several delivery approaches, results vary substantially between these studies. We analyse whether the assessment of myocardial viability may be important when evaluating effects of stem cell transplantation on parameters of left ventricular remodeling. Viability assessment could help to find the best type of stem cell and the best method of cell delivery to be used in chronic ischemic heart dysfunction.
Export Options
About this article
Cite this article as:
L. Sanchez Pedro, Sanz-Ruiz Ricardo, Eugenia Fernandez-Santos M., Villa Adolfo, Gutierrez Enrique, Fernandez Lucia, Vazquez Sandra, Jose Lorenzo M. and Fernandez-Aviles Francisco, Stem Cell Therapy in Chronic Ischemic Heart Dysfunction with and Without Viability, Cardiovascular & Hematological Disorders-Drug Targets 2010; 10 (3) . https://dx.doi.org/10.2174/1871529X11006030167
DOI https://dx.doi.org/10.2174/1871529X11006030167 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes
CNS & Neurological Disorders - Drug Targets Endothelin-1 Signaling in Vascular Physiology and Pathophysiology
Current Vascular Pharmacology Cellular Cardiomyoplasty and Cardiac Regeneration
Current Cardiology Reviews Can Lipoprotein-associated Phospholipase A<sub>2</sub> be Used as a Predictor of Long-term Outcome in Patients with Acute Coronary Syndrome?
Current Cardiology Reviews Adult Stem Cell Therapy for Cardiac Repair in Patients After Acute Myocardial Infarction Leading to Ischemic Heart Failure: An Overview of Evidence from the Recent Clinical Trials
Current Cardiology Reviews Targeting Antibody-Mediated Rejection in the Setting of ABOIncompatible Infant Heart Transplantation: Graft Accommodation vs. B Cell Tolerance
Current Drug Targets - Cardiovascular & Hematological Disorders Reactive Oxygen Species and Antioxidants in the Pathophysiology of Cardiovascular Disease: Does the Actual Knowledge Justify a Clinical Approach?
Current Vascular Pharmacology Mutation p.S335X in GATA4 Reduces its DNA Binding Affinity and Enhances Cell Apoptosis Associated with Ventricular Septal Defect
Current Molecular Medicine Signaling Epicenters: The Role of Caveolae and Caveolins in Volatile Anesthetic Induced Cardiac Protection
Current Pharmaceutical Design Gluten-dependent Intestinal Autoimmune Response
Current Pharmaceutical Design COVID-19 Invades Several Important Organs other than the Lungs: Organs Crosstalk
Coronaviruses Indications of Anti-Inflammatory Drugs in Cardiac Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells
Current Drug Targets New Analytical Tools for Studying Autoimmune Diseases
Current Pharmaceutical Design Global View on Rare Diseases: A Mini Review
Current Medicinal Chemistry Prognostic Role of miRNAs in Coronary Artery Disease
Current Topics in Medicinal Chemistry Tissue Doppler Imaging: Beautiful Noise
Current Cardiology Reviews Mechanisms of Drug Induced QT Interval Prolongation
Current Drug Safety Potential Adverse Effects Associated with Inhibition of p38α/β MAP Kinases
Current Topics in Medicinal Chemistry Signs and Related Mechanisms of Ethanol Hepatotoxicity
Current Drug Abuse Reviews